TCRR

TCR2 Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
TCR2 Therapeutics Inc TCRR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-5.70 -36.26% 10.02 19:59:36
Open Price Low Price High Price Close Price Prev Close
12.28 9.94 12.33 9.99 15.72
more quote information »

Recent News

Date Time Source Heading
9/17/202109:09EDGARCurrent Report Filing (8-k)
9/17/202107:30GLOBETCR² Therapeutics Announces Positive Interim Results from..
9/13/202106:45GLOBETCR2 Therapeutics to Announce Extended Results from Ongoing..
9/07/202106:45GLOBETCR² Therapeutics to Present at the H.C. Wainwright Global..
9/03/202116:25EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
9/02/202110:15DJNTCR Therapeutics Gets FDA Orphan Designation for Gavo-cel in..
9/02/202109:19GLOBETCR² Therapeutics Receives FDA Orphan Drug Designation for..
8/26/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
8/26/202107:46EDGARCurrent Report Filing (8-k)
8/26/202106:45GLOBETCR² Therapeutics Announces Renowned Translational Medicine..
8/17/202106:45GLOBETCR² Therapeutics Announces Upcoming Medical Meetings Update
8/05/202107:34SEEKTCR2 Therapeutics EPS misses by $0.03
8/05/202107:17EDGARQuarterly Report (10-q)
8/05/202107:02EDGARCurrent Report Filing (8-k)
8/05/202106:45GLOBETCR² Therapeutics Reports Second Quarter 2021 Financial..
7/27/202117:20EDGARStatement of Changes in Beneficial Ownership (4)
7/20/202107:45SEEKTCR2 Therapeutics appoints Peter Olagunju as CTO
7/20/202106:45GLOBETCR² Therapeutics Appoints Cell & Gene Therapy Manufacturing..
5/26/202106:45GLOBETCR² Therapeutics to Participate in Two Upcoming Conferences..
5/13/202107:16EDGARQuarterly Report (10-q)
5/13/202106:54SEEKTCR2 Therapeutics EPS misses by $0.05
5/13/202106:45GLOBETCR² Therapeutics Reports First Quarter 2021 Financial..
4/30/202116:29EDGARCurrent Report Filing (8-k)
4/30/202116:21EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/29/202106:45GLOBETCR² Therapeutics to Present at the Truist Securities Life..
4/10/202108:31GLOBETCR² Highlights Gavo-cel Translational Data and Emerging..
4/08/202106:45GLOBETCR² Therapeutics to Present at the Needham Healthcare..
4/02/202116:31EDGARStatement of Changes in Beneficial Ownership (4)
3/29/202108:01EDGARCurrent Report Filing (8-k)
3/29/202108:00GLOBETCR² Therapeutics Establishes Commercial-Scale Cell Therapy..
3/16/202116:54EDGARAutomatic Shelf Registration Statement of Securities of..
3/16/202116:07EDGARAnnual Report (10-k)
3/11/202107:27SEEKTCR2 Therapeutics EPS beats by $0.02
3/11/202107:01EDGARCurrent Report Filing (8-k)
3/11/202106:45GLOBETCR² Therapeutics Reports Fourth Quarter and Full Year 2020..
3/10/202116:45GLOBETCR² Presentations at American Association of Cancer..
3/08/202108:21EDGARStatement of Changes in Beneficial Ownership (4)
3/08/202108:17EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202108:00GLOBETCR² Therapeutics to Participate in Two Upcoming Conferences..
2/17/202108:00GLOBETCR² Therapeutics to Present at SVB Leerink Global..
2/09/202106:19EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202116:09EDGARStatement of Changes in Beneficial Ownership (4)
2/04/202116:06EDGARInitial Statement of Beneficial Ownership (3)
2/04/202108:11EDGARCurrent Report Filing (8-k)
2/04/202108:00GLOBETCR² Therapeutics Announces Commercial Cell Therapy Leader..
2/02/202115:17EDGARStatement of Ownership (sc 13g)
1/22/202117:06EDGARCurrent Report Filing (8-k)
1/21/202106:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/19/202122:02GLOBETCR² Therapeutics Announces Pricing of Public Offering of..
1/19/202106:24GLOBETCR² Therapeutics Announces Proposed Public Offering of..
See more news about this stock »


Your Recent History
NASDAQ
TCRR
TCR2 Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.